EKSO - Ekso Bionics Holdings, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue11,3327,35314,2218,661
Cost of Revenue7,0235,28410,3637,482
Gross Profit4,3092,0693,8581,179
Operating Expenses
Research Development5,1288,9978,4796,138
Selling General and Administrative24,44624,35721,15016,602
Non Recurring----
Others----
Total Operating Expenses36,59738,63839,99230,222
Operating Income or Loss-25,265-31,285-25,771-21,561
Income from Continuing Operations
Total Other Income/Expenses Net-1,7272,1632,3011,971
Earnings Before Interest and Taxes-25,265-31,285-25,771-21,561
Interest Expense-600-648-16-13
Income Before Tax-26,992-29,122-23,470-19,590
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-26,992-29,122-23,470-19,590
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-26,992-29,122-23,470-19,590
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-26,992-29,122-33,815-24,245